GI Oncology
News
Japanese study: S-1 adjuvant chemo improved pancreatic cancer survival
Major Finding: 2-year survival rates for Japanese patients who underwent resection of pancreatic cancer were 70% for those receiving postoperative...
Conference Coverage
Add-on nab-paclitaxel extends survival in metastatic pancreatic cancer
Major Finding: Median overall survival in patients with metastatic pancreatic cancer increased from 6.7 months on gemcitabine to 8.5 months on nab...
News
Bevacizumab boosts capecitabine response in elderly with metastatic colorectal cancer
Major Finding: Progression-free survival improved from 5.1 months on capecitabine to 9.1 months on capecitabine plus bevacizumab in elderly...
News
Adding cetuximab to chemoradiotherapy harmful in esophageal cancer
Major Finding: Adding cetuximab to chemoradiotherapy for localized esophageal cancer was associated with significantly shorter median survival...
From the AGA Journals
Prostatectomy vs. radiotherapy: 15-year functional outcomes are same
Major Finding: At 15-year follow-up, there were no significant differences in urinary, bowel, or sexual function between 1,164 men who had...
News
FDA approves bevacizumab for second-line combinations
News
Resecting residual gastrointestinal stromal tumors improved survival
Major Finding: Time to tumor progression was 88 months in 42 patients who had surgery for residual disease and 42 months in 92 patients given...
News
Second-line docetaxel benefits seen for esophagogastric cancers
Major Finding: Docetaxel significantly increased overall survival from a median of 3.6 months to 5.2 months and reduced pain scores in patients...
From the AGA Journals
Statins cut risk of hepatocellular carcinoma
Major Finding: Statin therapy reduced the risk of developing hepatocellular carcinoma by 37% overall; the risk reduction was stronger (48%) in...